Physician

Michael Izzo, MD

According to 2025 Medicare claims, Michael Izzo, MD (NPI: 1770077612) practices ophthalmology in the Reading, PA market, with the plurality of this provider's patient population coming from Berks, PA. This provider's primary affiliated billing organization is BERKS EYE PHYSICIANS & SURGEONS LTD (NPI: 1548221302; TIN: 231720360) and primary practice location at 19610-1100.

Izzo's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 442 traditional Medicare patients, billed 2,344 HCPCS/CPT codes, and received $204,727 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,091 prescription claims across 367 beneficiaries totaling $55,125 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 25 records totaling $646. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $2,361 to $55,125. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$102K$205K2022 Medicare payment: $14,296 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $54,103 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $204,727 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022115148$14,296
2023254664$54,103
20244422,344$204,727

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$28K$56K2018 Drug cost: $2,361 (USD; Tot_Drug_Cst)2019 Drug cost: $7,026 (USD; Tot_Drug_Cst)2020 Drug cost: $32,486 (USD; Tot_Drug_Cst)2021 Drug cost: $39,311 (USD; Tot_Drug_Cst)2022 Drug cost: $55,874 (USD; Tot_Drug_Cst)2023 Drug cost: $40,066 (USD; Tot_Drug_Cst)2024 Drug cost: $55,125 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
20181138$2,361
201962110$7,026
202074299$32,486
2021103303$39,311
2022130392$55,874
2023166437$40,066
20243671,091$55,125

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more165286$89
92014Established patient complete exam of visual system147161$89
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more185239$66
92083Exam of visual field with extended testing156183$44
92134Imaging of retina206240$28

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Prednisolone AcetatePrednisolone Acetate1904,736$5,543
LumiganBimatoprost15417$4,028
Tobramycin-DexamethasoneTobramycin/Dexamethasone1002,451$4,019
DifluprednateDifluprednate19449$1,813
FluorometholoneFluorometholone22526$1,577

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.25$646Bausch & Lomb Americas Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Michael Izzo, MD?

Tedicare shows public-source Medicare data for Michael Izzo, MD (NPI 1770077612), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Michael Izzo, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Michael Izzo, MD?

Michael Izzo, MD is linked to BERKS EYE PHYSICIANS & SURGEONS LTD (billing NPI 1548221302) in the available physician profile data.

Does Michael Izzo, MD have Open Payments data?

Michael Izzo, MD has 25 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.